288 completed, 46 unknown, 23 terminated, 18 recruiting. 140 Phase 3, 92 Phase 4, 76 Phase 2, 57 Phase 1, 40 Not applicable.
Follow Budesonide: new trials by email Literature Review of Budesonide trials Research Report on Budesonide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Little Lungs Study Calfactant, Budesonide - Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome | Phase 1 / Phase 2 | Not yet recruiting | University of Wisconsin, Madison | 24 | 2027-02-01 | 2026-11-02 |
| Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Budesonide/Glycopyrronium/Formoterol fumarate metered dose inhaler - Asthma, Uncontrolled Asthma | Not yet recruiting | AstraZeneca | 200 | 2027-01-29 | 2026-11-12 | |
| Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA) N0783, Alenia® (Formoterol 6 mcg / Budesonide 200 mcg) - Moderate Asthma | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-10-01 | 2026-10-23 | |
| Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps Budesonide - CRSwNP, Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis | Not applicable | Not yet recruiting | St. Paul's Sinus Centre | 10 | 2026-07-01 | 2026-04-14 |
| Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation Local Anesthesia With Conscious Sedation, General Anesthesia, VARIPULSE Pulsed Field Ablation System - Paroxysmal Atrial Fibrillation | Not applicable | Recruiting | China National Center for Cardiovascular Diseases | 390 | 2026-06-01 | 2026-10-26 |
| An Exploratory Study on Triple Inhaler Therapy in Patients With Early Lung Function Impairment Budesonide/glycopyrronium bromide/formoterol inhalation aerosol - Preserved Ratio Impaired Spirometry (PRISM) | Not applicable | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 23 | 2026-06-01 | 2026-05-19 |
| A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma Budesonide/formoterol fumarate Aerosphere, Budesonide/formoterol fumarate pMDI - Asthma | Phase 1 | Completed | AstraZeneca | 16 | 2026-03-05 | 2026-07-15 |
| Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome Modified Shenling Baizhu Powder, Placebo, Budesonide and Formoterol Fumarate Powder for Inhalation - Allergic Asthma | Not applicable | Not yet recruiting | Henan University of Traditional Chinese Medicine | 400 | 2026-01-15 | 2026-01-20 |
| Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration Syndrome Budesonide, Normal Saline - Meconium Aspiration Syndrome | Phase 3 | Completed | Khyber Teaching Hospital | 60 | 2025-11-28 | 2026-08-13 |
| A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation Budesonide/Glycopyrronium/Formoterol Fumarate, Placebo, Metered dose inhaler - Chronic Obstructive Pulmonary Disease, Hyperinflation | Phase 4 | Recruiting | AstraZeneca | 56 | 2025-11-24 | 2026-09-18 |
| Efficacy and Safety of CP006 Inhalation Powder in Participants With Asthma Budesonide, Formoterol Fumarate, and Umeclidinium Bromide, Budesonide and Formoterol Fumarate, Placebo for CP006 Inhalation Powder - Asthma | Phase 2 | Completed | Shanghai Xin Huanghe Pharmaceutical Co., Ltd. | 150 | 2025-11-21 | 2026-09-08 |
| Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study Budesonide/Glycopyrronium/Formoterol (BGF), Fluticasone Furoate/Umeclidinium/Vilanterol (FUV) - COPD, Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Thammasat University | 22 | 2025-04-01 | 2026-02-02 |
| Early Screening of Young COPD and Pre-COPD Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol - Pulmonary Disease, Chronic Obstructive | Not yet recruiting | yanmengkang | 100 | 2025-03-01 | 2025-02-25 | |
| Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels Budesonide - Chronic Obstructive Pulmonary Disease | Phase 4 | Recruiting | Maria Joyera Rodríguez | 135 | 2025-02-12 | 2026-07-20 |
| A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy Adults Treatment A: BGF MDI HFO, Treatment B: BGF MDI HFA - Healthy Participants | Phase 1 | Completed | AstraZeneca | 105 | 2025-01-23 | 2025-06-05 |
| Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans Budiair® 200ug/puff inhalation aerosol, budesonide 200ug/puff inhalation aerosol - Bioequivalence Study in Healthy Subjects | Not applicable | Completed | Lunan Better Pharmaceutical Co., LTD. | 32 | 2024-12-30 | 2025-04-11 |
| Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy TARPEYO® - IgA Nephropathy | Phase 4 | Active not recruiting | Calliditas Therapeutics AB | 60 | 2024-12-17 | 2026-09-24 |
| Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Lunsekimig, Short-Acting Beta Agonists (SABA), Placebo - Asthma | Phase 2 | Active not recruiting | Sanofi | 556 | 2024-11-07 | 2026-09-22 |
| Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients. Budesonide-Formoterol treatment - Cough-Variant Asthma | Phase 4 | Completed | AstraZeneca | 1000 | 2024-10-18 | 2025-09-18 |
| Nasal Obstruction With Oxymetazoline and Corticosteroids Oxymetazoline Nasal Spray, Budesonide nasal spray - Nasal Obstruction | Phase 2 | Recruiting | Washington University School of Medicine | 80 | 2024-10-15 | 2025-09-11 |
Showing 20 of 406. Sign in to see all of them.
Asthma (167) · Pulmonary Disease, Chronic Obstructive (64) · Eosinophilic Esophagitis (12) · Bronchopulmonary Dysplasia (11) · Crohn Disease (11) · Colitis, Ulcerative (10) · Respiratory Distress Syndrome (9) · Rhinitis, Allergic (9) · Respiratory Sounds (8) · Premature Birth (7) · Disease (6) · Nasal Polyps (6) · Sinusitis (6) · COVID-19 (5) · Rhinitis, Allergic, Seasonal (5)
AstraZeneca (88) · Dr. Falk Pharma GmbH (16) · Orion Corporation, Orion Pharma (12) · Intech Biopharm Ltd. (6) · Mayo Clinic (6) · Bausch Health Americas, Inc. (5) · Beijing Tongren Hospital (5) · Chiesi Farmaceutici S.p.A. (5) · Pearl Therapeutics, Inc. (5) · Bond Avillion 2 Development LP (4) · Eurofarma Laboratorios S.A. (4) · GlaxoSmithKline (4) · Medical University of Lodz (4) · St. Paul's Hospital, Canada (4) · Zhujiang Hospital (4)
United States (113) · Germany (49) · China (40) · Canada (37) · United Kingdom (32) · Poland (25) · Denmark (17) · Italy (17) · Spain (17) · Brazil (16) · France (16) · Sweden (15) · Hungary (14) · Mexico (13) · Argentina (12)
Catherine Bonuccelli (9) · Bertil Andersson (7) · Christer Hultquist, MD (4) · Frank Albers, MD, PhD (4) · Tomas Andersson, MD (4) · Kimmo Ingman, MD, PhD (3) · Ralph Mueller, PhD (3) · Stephan Miehlke, Prof. (3) · Ulla Sairanen, MSc (3) · Alberto Papi, MD (2)
PMID 22329608, PMID 25670896, PMID 29331313, PMID 36472162, PMID 42551404, PMID 19897551, PMID 19995138, PMID 20600032, PMID 22383665, PMID 25644096, PMID 26351971, PMID 27416045, PMID 27912982, PMID 28069068, PMID 28420280, PMID 32738928, PMID 33152467, PMID 33548020, PMID 35815359, PMID 41677208, PMID 10430726, PMID 10655252, PMID 11401887, PMID 11491153, PMID 11549531, PMID 12204862, PMID 12570114, PMID 15591470, PMID 15764724, PMID 15764761, PMID 16055882, PMID 16135736, PMID 16164444, PMID 16650970, PMID 16687712, PMID 17046300, PMID 17107988, PMID 17148626, PMID 17296644, PMID 17905575, PMID 17931847, PMID 18216054, PMID 18295023, PMID 18426851, PMID 18486661, PMID 18550609, PMID 18595959, PMID 18951618, PMID 18958997, PMID 18972276
2015 (4), 2008 (3), 2014 (3), 2016 (3), 2018 (3), U10HL064287 (3), U10HL064288 (3), U10HL064295 (3), U10HL064305 (3), U10HL064307 (3), U10HL064313 (3), 2023 (2), UL1RR024150 (2), 1UG3HL141722-01A1 (1), 2004 (1)